title: Protective effectiveness of hantavirus vaccine.
abstract: A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.
authors.affiliation: National Cancer Center, Goyang, Republic of Korea. bachism@empal.com
authors.forename: Keeho
authors.initials: K
authors.lastname: Park
authors.forename: Chang Soo
authors.initials: CS
authors.lastname: Kim
authors.forename: Ki-Tae
authors.initials: KT
authors.lastname: Moon
mesh_terms: D016022:Case-Control Studies; D004306:Dose-Response Relationship, Immunologic; D006480:Hemorrhagic Fever with Renal Syndrome / Q000517:prevention & control*; D006801:Humans; D007723:Korea / Q000453:epidemiology; D008889:Military Personnel; D013997:Time Factors; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D014765:Viral Vaccines